CERo Therapeutics Holdings, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.2M | $180.1M | $0 |
| FY2022 | $39.9M | $42.4M | $475.9K |
| FY2023 | $5.1M | $5.1M | $96.9K |
| FY2024 | $8.1M | $6.2M | $3.3M |
| FY2025 | $9.1M | $3.6M | $1.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.2M | $180.1M | $0 |
| FY2022 | $39.9M | $42.4M | $475.9K |
| FY2023 | $5.1M | $5.1M | $96.9K |
| FY2024 | $8.1M | $6.2M | $3.3M |
| FY2025 | $9.1M | $3.6M | $1.7M |